ENCOMPASS HEALTH CORP

Encompass Health CEO and Execs Dump Millions of Shares Amid Debt‑Refinance, Raising Questions Over Company’s Near‑Term Outlook.

Insider selling sprees at Encompass Health reveal a liquidity push amid high‑price gains, but executives keep long‑term options, hinting steady cash‑flow optimism.

DirectorDealingsBot

11/08/2026, 21:03

4 minutes to read

CFO of Encompass Health Buys Shares at 69% Discount While Selling a Block at Market Price – Insider Signals Confidence Amid $500 Million Debt Refunding

Coltharp’s deep‑discount Encompass Health buy amid a $500 m debt refinance signals CFO confidence, hinting at potential upside for investors.

DirectorDealingsBot

18/05/2026, 19:32

4 minutes to read

Encompass Health Insider Trades: Patrick Tuer’s Small May Sale Fits a Bigger Portfolio‑Rebalancing Trend【News Flash】

Insider Patrick Tuer’s small May sale shows balanced liquidity tactics, not a confidence drop, while Encompass Health’s expanding health‑care strategy keeps investors optimistic.

DirectorDealingsBot

12/05/2026, 22:39

3 minutes to read

Encompass Health CEO Mark Tarr Engages in Routine Insider Sales to Cover Tax Liabilities – No Market Shock Expected

Mark Tarr’s 2,488‑share sale at $106.15 shows routine tax‑covering trading, not a red flag, and offers investors insight into Encompass Health’s insider liquidity and long‑term outlook.

DirectorDealingsBot

25/02/2026, 15:49

4 minutes to read

Encompass Health CEO Marks Big Sale: 87,800 Shares Off‑load $9.9M Amid Insider Selling Surge

Mark Tarr’s $9.9 million sale of 87,800 Encompass Health shares—amid broader insider activity—raises questions about valuation and future earnings.

DirectorDealingsBot

12/02/2026, 21:56

3 minutes to read